Home › Trials › NCT06316453
Clinical trial No longer in our active list Observational Ages 30 to 90

Assessing Atherosclerotic Cardiovascular Disease Risk in Pakistan

Official title: Prospective Assessment of Atherosclerotic Cardiovascular Disease (ASCVD) Risk in Adults (30 Years and Above) in Pakistan: A Multi-Year Study Investigating Incidence, Validation, and Management Strategies

Run by Advanced Education & Research Center · NCT06316453 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is tracking people over 30 in Pakistan for 10 years to see how likely they are to develop heart disease and to gather important health information for the country.

More Atherosclerotic Cardiovascular Disease (ASCVD) trials

Quick facts

Study typeObservational
Ages30 Years to 90 Years
SexAll
Enrollment3513 (estimated)
SponsorAdvanced Education & Research Center
Academic / other
Locations1 site (Karachi, Sindh)
Trial IDNCT06316453 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 30 years and older without a known history of atherosclerotic cardiovascular diseases.

Probably not a fit

Patients with a confirmed diagnosis of ASCVD or those with cancer will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to follow individuals aged 30 and above in Pakistan for 10 years to assess their risk of atherosclerotic cardiovascular diseases (ASCVD). It will evaluate risk assessment scores to identify high-risk individuals and track the incidence of ASCVD events over the long term. The study addresses a significant gap in local data regarding ASCVD, particularly in diverse economic settings. By focusing on a broad demographic, it seeks to provide insights into the evolving landscape of cardiovascular health in Pakistan.

Why it matters

Potential benefit: If successful, this study could lead to improved risk assessment and management strategies for preventing ASCVD in the Pakistani population.

How similar studies have gone: Other studies have shown success in assessing cardiovascular risk in diverse populations, but this specific approach in Pakistan is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Individuals of any gender
* Individuals aged 30 years and above
* The study ensured a diverse representation to encompass a broad spectrum of experiences and risk factors within this age group
* Individuals without pre-existing cardiovascular conditions

Exclusion Criteria:

* Individuals with a confirmed diagnosis of ASCVD
* Confirmed cases of cancer
* participants who express a refusal to provide informed consent

Where it's running

  • Advanced Education Institute and Research Center
    Karachi, Sindh, Pakistan     Recruiting

Study contacts

  • Principal investigator: Tariq Ashraf — National Institute of Cardiovascular Diseases
  • Study coordinator: Sadaf Ahmed, PhD
  • Email: sadaf@aeirc-edu.com
  • Phone: 03333061127

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.